JBC117, a novel anticancer lead compound targeting Pygo2 PHD, effectively antagonizes beta-catenin-dependent cell activity, inhibits cancer cell migration and invasion, and induces apoptosis [1].
Molecular Weight:
442.55
CAS Number:
[1214531-21-1]
Formula:
C28H30N2O3
Target:
Apoptosis
T86759
* VAT and and shipping costs not included. Errors and price changes excepted
